Haleon (LON:HLN) Issues Earnings Results

Haleon (LON:HLN - Get Free Report) issued its earnings results on Friday. The company reported GBX 15.80 ($0.20) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Haleon had a net margin of 9.66% and a return on equity of 6.54%.

Haleon Stock Performance

Shares of HLN traded up GBX 13.21 ($0.17) during mid-day trading on Monday, reaching GBX 408.51 ($5.15). The company's stock had a trading volume of 17,311,160 shares, compared to its average volume of 26,942,223. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 53.36. The stock has a market cap of £36.87 billion, a P/E ratio of 34.36, a PEG ratio of 1.49 and a beta of 0.19. Haleon has a 1-year low of GBX 308.37 ($3.89) and a 1-year high of GBX 411.40 ($5.19). The business has a 50-day simple moving average of GBX 380.01 and a two-hundred day simple moving average of GBX 379.31.

About Haleon

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.